# Safety and Immunogenicity Study of a Dengue Virus DNA Vaccine

> **NCT00290147** · PHASE1 · COMPLETED · sponsor: **U.S. Army Medical Research and Development Command** · enrollment: 22 (actual)

## Conditions studied

- Dengue

## Interventions

- **BIOLOGICAL:** D1ME100 (dengue-1 premembrane/envelope DNA vaccine)

## Key facts

- **NCT ID:** NCT00290147
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2006-12
- **Final completion:** 2009-04
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2017-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00290147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00290147, "Safety and Immunogenicity Study of a Dengue Virus DNA Vaccine". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00290147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*